Divergent Q4 Earnings: Avanos Medical Outperforms as American Tower Faces Churn
Key Takeaways
- Avanos Medical (AVNS) reported a strong 2025 finish with sales exceeding revised targets, driven by its Specialty Nutrition Systems segment.
- In contrast, American Tower (AMT) faces a challenging 2026 outlook due to a payment default by DISH and increased international churn.
Key Intelligence
Key Facts
- 1Avanos Medical (AVNS) sales exceeded the company's revised 2025 guidance range.
- 2AVNS reported full-year 2025 earnings at the high end of its projected range.
- 3Specialty Nutrition Systems (SNS) was identified as the primary driver of AVNS's performance.
- 4American Tower (AMT) warned that its 2026 outlook is impacted by a payment default from DISH.
- 5AMT reported elevated churn rates across portions of its international infrastructure footprint.
| Metric/Focus | ||
|---|---|---|
| 2025 Performance | Topped revised sales range | Described as 'great year' despite headwinds |
| Primary Growth Driver | Specialty Nutrition Systems (SNS) | Data centers and 5G infrastructure |
| Key Headwind | Potential tariff impacts | DISH payment default and intl. churn |
| 2026 Strategy | Operating efficiency and mitigation | Managing tenant defaults and churn |
Who's Affected
Analysis
The fourth-quarter earnings reports for Avanos Medical and American Tower highlight a stark divergence in the operational landscapes of medical technology and telecommunications infrastructure. While Avanos Medical successfully navigated a complex macroeconomic environment to deliver results at the high end of its guidance, American Tower is grappling with counterparty risk and international volatility that threaten to dampen its 2026 growth trajectory. This contrast underscores the importance of sector-specific tailwinds—such as the steady demand for specialty medical nutrition—versus the systemic risks inherent in large-scale infrastructure leasing and tenant credit quality.
Avanos Medical’s performance in 2025 was anchored by its Specialty Nutrition Systems (SNS) business, which continues to be a primary growth engine for the company. By finishing the year with sales that topped its revised range and earnings at the high end of expectations, management has demonstrated effective execution of its strategic priorities. The SNS segment's resilience is particularly noteworthy given the broader volatility in elective procedure volumes that often impacts the medical device sector. The company’s forward-looking strategy now shifts toward defensive measures, specifically mitigating potential tariff impacts and driving further operating efficiencies. This proactive stance is critical as the medical device industry faces ongoing supply chain scrutiny and pricing pressures. Investors should view Avanos as a company successfully pivoting from a period of restructuring toward a more stable, margin-focused growth phase. The emphasis on mitigating tariff impacts suggests that management is already modeling various geopolitical scenarios, a move that provides a layer of predictability for shareholders in an otherwise uncertain trade environment.
The fourth-quarter earnings reports for Avanos Medical and American Tower highlight a stark divergence in the operational landscapes of medical technology and telecommunications infrastructure.
Conversely, American Tower’s recent disclosures reveal the vulnerabilities within the wireless infrastructure REIT model, particularly concerning counterparty concentration. Despite CEO Steven Vondran’s emphasis on the durable long-term demand for 5G infrastructure and interconnection-rich data centers, the immediate outlook is clouded by the financial instability of major tenants. The payment default by DISH is a significant blow, forcing a recalibration of the 2026 outlook and raising questions about the credit quality of the emerging fourth carrier in the U.S. market. When combined with elevated churn in international markets—specifically in regions where carrier consolidation has reduced the number of available tenants—the company faces a period of transition where organic growth must offset these localized headwinds. The strength of American Tower’s data center portfolio, bolstered by its CoreSite acquisition in previous years, remains a silver lining. These assets are increasingly vital for AI-driven workloads, but they may not be enough to fully insulate the firm from the broader consolidation and financial distress occurring among global telecom carriers.
What to Watch
The broader market context reveals a shift in investor sentiment toward companies that can demonstrate self-help margin improvements over those reliant on macro-driven expansion. Avanos Medical fits this narrative, focusing on internal efficiencies and niche market dominance in nutrition. Meanwhile, American Tower’s situation highlights the landlord's dilemma in the telecom space: while the underlying technology (5G and Cloud) is essential, the financial health of the tenants paying the rent is not always guaranteed. This earnings cycle serves as a reminder that infrastructure plays are not always the bond-proxies they are marketed to be, especially when tenant defaults enter the equation. Analysts will be looking for AMT to provide more clarity on how it intends to backfill the revenue lost from DISH and whether the international churn is a one-time reset or a multi-year trend.
Looking ahead, the market will likely reward Avanos Medical for its consistency and clear path to margin expansion, provided it can successfully navigate the looming tariff landscape without sacrificing its R&D pipeline. For American Tower, the focus will remain on the stabilization of its tenant base and the potential for its data center assets to provide a higher-growth alternative to traditional tower leasing. The DISH default serves as a cautionary tale for the infrastructure sector, highlighting that even durable demand cannot entirely protect against the credit risks of key industry players. Analysts will be watching closely to see if other tower operators report similar churn patterns or if American Tower’s issues are isolated to specific international regions and tenant relationships. The divergence between these two companies illustrates that in the current market, operational excellence and tenant quality are the primary determinants of post-earnings performance.
How we covered this story
Every story in our finance coverage is assembled from multiple primary sources, cross-referenced for factual consistency, and scored along three independent dimensions: sentiment, operational impact, and source-cluster confidence. Single-source rumors and unverifiable claims do not pass our editorial gate. When a story shows "Verified by N sources" with N≥2, the development is independently corroborated; when N=1, we mark it explicitly so readers can weigh the signal accordingly.
Impact scoring uses a 1-10 scale weighted toward regulatory, financial, and operational consequence rather than coverage volume. A topic that runs in every outlet but moves no real decisions ranks lower than a niche regulatory filing that reshapes how operators in the finance space have to behave. Read our full methodology for the scoring rubric, our glossary for term definitions, and our trends index for the longitudinal view across the beat.
| Signal on this page | What it tells you |
|---|---|
| Verified by N sources | Independent corroboration count. N≥2 is our confidence floor; N=1 is marked explicitly. |
| Impact score (1-10) | Regulatory + financial + operational weight. 8+ signals an experienced-operator action item. |
| Sentiment | Five-tier classification trained on labeled finance-specific corpora. |
| Timeline | Where applicable, the related-events sequence that contextualizes today's development. |